{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:43:14Z","timestamp":1793371394321,"version":"4.5.0"},"reference-count":64,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HD071834"],"award-info":[{"award-number":["T32HD071834"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HD052892-15"],"award-info":[{"award-number":["K12HD052892-15"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 CA252178"],"award-info":[{"award-number":["K08 CA252178"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001445","name":"Alex\u2019s Lemonade Stand Foundation for Childhood Cancer","doi-asserted-by":"publisher","award":["Young Investigator Award"],"award-info":[{"award-number":["Young Investigator Award"]}],"id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UPMC Children\u2019s Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ewing sarcoma is an aggressive cancer diagnosed in adolescents and young adults. Inhibition of TGF\u03b2 is being tested in limited clinical trials for relapsed Ewing sarcoma. TGF\u03b2 is an immunosuppressive cytokine that exists in latent and active states. The functional impact of TGF\u03b2 inhibition on the Ewing tumor microenvironment (TME) and on Ewing tumor behavior remains largely unknown. In this study, we use single-cell RNA sequencing analysis of human Ewing tumors to demonstrate that immune cells are the largest contributors of TGFB1 expression in the human Ewing TME. We utilize a humanized mouse model of Ewing sarcoma to demonstrate that TME signatures in these models differ significantly from Ewing sarcoma tumors developed in immunodeficient mice. Using this humanized model, we investigate the effect of TGF\u03b2 inhibition on the Ewing sarcoma TME during radiotherapy, a treatment that is commonly used to treat unresectable, metastatic, and relapsed\/refractory Ewing sarcoma that is known to enhance TGF\u03b2 activation in multiple cancers. Utilizing a trivalent ligand TGF\u03b2 trap to inhibit TGF\u03b2, we demonstrate that in combination with radiotherapy, TGF\u03b2 inhibition both increases Ewing sarcoma immune cell infiltration and decreases lung metastatic burden in vivo. These data demonstrate the value of immunocompetent models to address immune-biological preclinical questions in Ewing sarcoma and demonstrate that TGF\u03b2 inhibition during radiotherapy is a promising strategy to enhance antitumor immune response and improve treatment efficacy for metastatic Ewing sarcoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This work demonstrates the importance of disrupting immunosuppression during radiotherapy to reduce lung metastatic potential in Ewing sarcoma. Humanized mouse models of Ewing sarcoma are also established as an immunocompetent preclinical tool to ask therapeutic questions about the Ewing TME.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0346","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:31:11Z","timestamp":1754652671000},"page":"1441-1457","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["TGF\u03b2 Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-448X","authenticated-orcid":false,"given":"Jessica D.","family":"Daley","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."},{"name":"2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-7219","authenticated-orcid":false,"given":"Elina","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2849-4353","authenticated-orcid":false,"given":"David","family":"Ferraro","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8585-1063","authenticated-orcid":false,"given":"A. Carolina","family":"Tufino","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-680X","authenticated-orcid":false,"given":"Nathanael","family":"Bailey","sequence":"additional","affiliation":[{"name":"3Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0598-1673","authenticated-orcid":false,"given":"Shanthi","family":"Bhaskar","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9348-9551","authenticated-orcid":false,"given":"Nivitha","family":"Periyapatna","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9056-1255","authenticated-orcid":false,"given":"Ian","family":"MacFawn","sequence":"additional","affiliation":[{"name":"2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2474-5623","authenticated-orcid":false,"given":"Sean","family":"Hartwick","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."},{"name":"4Rangos Research Center Animal Imaging Core, UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7529-040X","authenticated-orcid":false,"given":"Sheryl","family":"Kunning","sequence":"additional","affiliation":[{"name":"5Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-9378","authenticated-orcid":false,"given":"Cynthia","family":"Hinck","sequence":"additional","affiliation":[{"name":"6Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-0207","authenticated-orcid":false,"given":"Tullia C.","family":"Bruno","sequence":"additional","affiliation":[{"name":"2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."},{"name":"5Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0771-9486","authenticated-orcid":false,"given":"Adam C.","family":"Olson","sequence":"additional","affiliation":[{"name":"7Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9875-5043","authenticated-orcid":false,"given":"Linda M.","family":"McAllister-Lucas","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."},{"name":"2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-8054","authenticated-orcid":false,"given":"Andrew P.","family":"Hinck","sequence":"additional","affiliation":[{"name":"6Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8172-1648","authenticated-orcid":false,"given":"Kristine","family":"Cooper","sequence":"additional","affiliation":[{"name":"8UPMC Hillman Cancer Center Biostatistics Facility, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6105-1704","authenticated-orcid":false,"given":"Riyue","family":"Bao","sequence":"additional","affiliation":[{"name":"2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."},{"name":"9Department of Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-3129","authenticated-orcid":false,"given":"Anthony R.","family":"Cillo","sequence":"additional","affiliation":[{"name":"2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."},{"name":"10Center for Systems Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3925-3243","authenticated-orcid":false,"given":"Kelly M.","family":"Bailey","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."},{"name":"2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"2025082622375068300_bib1","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"2025082622375068300_bib2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.semcancer.2022.02.011","article-title":"Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells","volume":"86","author":"Berg","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"2025082622375068300_bib3","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1038\/s41388-018-0199-y","article-title":"Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation","volume":"37","author":"Yoo","year":"2018","journal-title":"Oncogene"},{"key":"2025082622375068300_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.seminoncol.2019.07.003","article-title":"Ionizing radiation effects on the tumor microenvironment","volume":"46","author":"Portella","year":"2019","journal-title":"Semin Oncol"},{"key":"2025082622375068300_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"2025082622375068300_bib6","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"2025082622375068300_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"2025082622375068300_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2015.07.044","article-title":"Tumor microenvironment and cancer therapy resistance","volume":"380","author":"Sun","year":"2016","journal-title":"Cancer Lett"},{"key":"2025082622375068300_bib9","doi-asserted-by":"crossref","first-page":"e25961","DOI":"10.4161\/onci.25961","article-title":"Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy","volume":"2","author":"Devaud","year":"2013","journal-title":"Oncoimmunology"},{"key":"2025082622375068300_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"key":"2025082622375068300_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra2028910","article-title":"Ewing's sarcoma","volume":"384","author":"Riggi","year":"2021","journal-title":"N Engl J Med"},{"key":"2025082622375068300_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pbc.25709","article-title":"Identification of discrete prognostic groups in Ewing sarcoma","volume":"63","author":"Karski","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"2025082622375068300_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MPH.0b013e31816e22f3","article-title":"Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance Epidemiology and End Results data","volume":"30","author":"Esiashvili","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"2025082622375068300_bib14","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1158\/1078-0432.CCR-23-1111","article-title":"Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment","volume":"29","author":"Wrenn","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2025082622375068300_bib15","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/s41467-022-29898-x","article-title":"Hypoxia-activated neuropeptide Y\/Y5 receptor\/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat Commun"},{"key":"2025082622375068300_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-023-01750-w","article-title":"Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship","volume":"22","author":"Ceranski","year":"2023","journal-title":"Mol Cancer"},{"key":"2025082622375068300_bib17","doi-asserted-by":"crossref","first-page":"34141","DOI":"10.18632\/oncotarget.9388","article-title":"Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model","volume":"8","author":"Minas","year":"2017","journal-title":"Oncotarget"},{"key":"2025082622375068300_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/359162a0","article-title":"Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours","volume":"359","author":"Delattre","year":"1992","journal-title":"Nature"},{"key":"2025082622375068300_bib19","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1172\/JCI72399","article-title":"Ewing\u2019s sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors","volume":"124","author":"Tanaka","year":"2014","journal-title":"J Clin Invest"},{"key":"2025082622375068300_bib20","doi-asserted-by":"crossref","first-page":"e69734","DOI":"10.7554\/eLife.69734","article-title":"Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth","volume":"11","author":"Vasileva","year":"2022","journal-title":"Elife"},{"key":"2025082622375068300_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00428-018-2316-2","article-title":"Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing\u2019s sarcoma family of tumors (ESFT)","volume":"472","author":"Machado","year":"2018","journal-title":"Virchows Arch"},{"key":"2025082622375068300_bib22","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1158\/1078-0432.CCR-22-1471","article-title":"Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks","volume":"28","author":"Cillo","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025082622375068300_bib23","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1158\/2767-9764.CRC-23-0027","article-title":"Ewing sarcoma single-cell transcriptome analysis reveals functionally impaired antigen-presenting cells","volume":"3","author":"Visser","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2025082622375068300_bib24","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1158\/1078-0432.CCR-24-2040","article-title":"Single cell RNA-sequencing of Ewing sarcoma tumors demonstrates transcriptional heterogeneity and clonal evolution","volume":"31","author":"Goodspeed","year":"2025","journal-title":"Clin Cancer Res"},{"key":"2025082622375068300_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2020.1744568","article-title":"TGF-beta: a master immune regulator","volume":"24","author":"Larson","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"2025082622375068300_bib26","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"2025082622375068300_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.29065","article-title":"Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children\u2019s Oncology Group","volume":"121","author":"DuBois","year":"2015","journal-title":"Cancer"},{"key":"2025082622375068300_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pbc.10472","article-title":"Ewing sarcoma: radiation dose and target volume","volume":"42","author":"Donaldson","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"2025082622375068300_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/pbc.25294","article-title":"Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma","volume":"62","author":"Casey","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2025082622375068300_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jbo.2018.02.004","article-title":"Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations","volume":"12","author":"Jacques","year":"2018","journal-title":"J Bone Oncol"},{"key":"2025082622375068300_bib31","doi-asserted-by":"crossref","first-page":"86087","DOI":"10.18632\/oncotarget.13343","article-title":"A novel highly potent trivalent TGF-\u03b2 receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"key":"2025082622375068300_bib32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/1535-7163.MCT-20-0944","article-title":"Novel TGF\u03b2 inhibitors ameliorate oral squamous cell carcinoma progression and improve the antitumor immune response of anti-PD-L1 immunotherapy","volume":"20","author":"Ludwig","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2025082622375068300_bib33","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1038\/s41388-019-0958-4","article-title":"MALT1 is a critical mediator of PAR1-driven NF-\u03baB activation and metastasis in multiple tumor types","volume":"38","author":"McAuley","year":"2019","journal-title":"Oncogene"},{"key":"2025082622375068300_bib34","doi-asserted-by":"crossref","first-page":"e135188","DOI":"10.1172\/jci.insight.135188","article-title":"Wnt\/\u03b2-catenin-activated Ewing sarcoma cells promote the angiogenic switch","volume":"5","author":"Hawkins","year":"2020","journal-title":"JCI Insight"},{"key":"2025082622375068300_bib35","doi-asserted-by":"crossref","first-page":"20474","DOI":"10.1038\/s41598-023-47996-8","article-title":"The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumors","volume":"13","author":"Eghtedari","year":"2023","journal-title":"Sci Rep"},{"key":"2025082622375068300_bib36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/1078-0432.CCR-22-2292","article-title":"Pilot study of recurrent Ewing\u2019s sarcoma management with vigil\/temozolomide\/irinotecan and assessment of circulating tumor (ct) DNA","volume":"29","author":"Anderson","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2025082622375068300_bib37","doi-asserted-by":"crossref","first-page":"e1674113","DOI":"10.1080\/2162402X.2019.1674113","article-title":"Prognostic profiling of the immune cell microenvironment in Ewing\u2019s Sarcoma Family of Tumors","volume":"8","author":"Stahl","year":"2019","journal-title":"Oncoimmunology"},{"key":"2025082622375068300_bib38","first-page":"4568","article-title":"Humanized mouse model: a review on preclinical applications for cancer immunotherapy","volume":"10","author":"Yin","year":"2020","journal-title":"Am J Cancer Res"},{"key":"2025082622375068300_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"2025082622375068300_bib40","article-title":"Ewing sarcoma","author":"de Alava","year":"2024","journal-title":"Appl Radiol"},{"key":"2025082622375068300_bib41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/03009858221083038","article-title":"Canine and murine models of osteosarcoma","volume":"59","author":"Beck","year":"2022","journal-title":"Vet Pathol"},{"key":"2025082622375068300_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","article-title":"Ewing sarcoma","volume":"4","author":"Gr\u00fcnewald","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025082622375068300_bib43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/path.2819","article-title":"Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression","volume":"223","author":"Berghuis","year":"2011","journal-title":"J Pathol"},{"key":"2025082622375068300_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13569-016-0053-3","article-title":"Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours","volume":"6","author":"Inagaki","year":"2016","journal-title":"Clin Sarcoma Res"},{"key":"2025082622375068300_bib45","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/0008-5472.CAN-14-3511","article-title":"TGF\u03b2 is a master regulator of radiation therapy-induced antitumor immunity","volume":"75","author":"Vanpouille-Box","year":"2015","journal-title":"Cancer Res"},{"key":"2025082622375068300_bib46","doi-asserted-by":"crossref","first-page":"9527","DOI":"10.2147\/OTT.S224013","article-title":"Blocking TGF-beta signaling to enhance the efficacy of immune checkpoint inhibitor","volume":"12","author":"Bai","year":"2019","journal-title":"Onco Targets Ther"},{"key":"2025082622375068300_bib47","first-page":"1077","article-title":"Redox-mediated activation of latent transforming growth factor-beta 1","volume":"10","author":"Barcellos-Hoff","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2025082622375068300_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1667\/RR0695.1","article-title":"Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species","volume":"166","author":"Jobling","year":"2006","journal-title":"Radiat Res"},{"key":"2025082622375068300_bib49","doi-asserted-by":"crossref","first-page":"155709","DOI":"10.1016\/j.cyto.2021.155709","article-title":"TGF-beta signaling in cancer radiotherapy","volume":"148","author":"Wang","year":"2021","journal-title":"Cytokine"},{"key":"2025082622375068300_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4255\/mcpharmacol.09.06","article-title":"Role of radiation-induced TGF-beta signaling in cancer therapy","volume":"1","author":"Dancea","year":"2009","journal-title":"Mol Cell Pharmacol"},{"issue":"Suppl 16","key":"2025082622375068300_bib51","doi-asserted-by":"crossref","first-page":"11529","DOI":"10.1200\/JCO.2023.41.16_suppl.11529","article-title":"Evaluation of local control strategies on patterns of treatment failure in patients with localized ewing sarcoma treated on AEWS1031: a report from the children\u2019s oncology group","volume":"41","author":"Ahmed","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025082622375068300_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2006.12.057","article-title":"Inhibition of transforming growth factor-beta signaling in normal lung epithelial cells confers resistance to ionizing radiation","volume":"68","author":"Reeves","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025082622375068300_bib53","doi-asserted-by":"crossref","first-page":"e005267","DOI":"10.1136\/jitc-2022-005267","article-title":"Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-\u03b2-trap bifunctional antibody, in patients with advanced solid tumors","volume":"11","author":"Tolcher","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2025082622375068300_bib54","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/onc.2016.498","article-title":"Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation\/migration choices in Ewing sarcoma cells","volume":"36","author":"Franzetti","year":"2017","journal-title":"Oncogene"},{"key":"2025082622375068300_bib55","doi-asserted-by":"crossref","first-page":"1044707","DOI":"10.3389\/fonc.2022.1044707","article-title":"The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: a review","volume":"12","author":"Apfelbaum","year":"2022","journal-title":"Front Oncol"},{"key":"2025082622375068300_bib56","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1054\/bjoc.2001.1796","article-title":"Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials","volume":"84","author":"Johnson","year":"2001","journal-title":"Br J Cancer"},{"key":"2025082622375068300_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drudis.2012.02.003","article-title":"Predictive in vivo animal models and translation to clinical trials","volume":"17","author":"Cook","year":"2012","journal-title":"Drug Discov Today"},{"key":"2025082622375068300_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11912-023-01380-x","article-title":"CAR-T therapies in solid tumors: opportunities and challenges","volume":"25","author":"Guzman","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"2025082622375068300_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"2025082622375068300_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","article-title":"CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol Cancer"},{"key":"2025082622375068300_bib61","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.3390\/cancers14194902","article-title":"Regulation of metastasis in ewing sarcoma","volume":"14","author":"Li","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025082622375068300_bib62","doi-asserted-by":"crossref","first-page":"82049","DOI":"10.18632\/oncotarget.18282","article-title":"Ionising radiation increases permeability of endothelium through ADAM10-mediated cleavage of VE-cadherin","volume":"8","author":"Kabacik","year":"2017","journal-title":"Oncotarget"},{"key":"2025082622375068300_bib63","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-23-3206","article-title":"Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites","volume":"30","author":"Hou","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2025082622375068300_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/13854","article-title":"Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein","volume":"23","author":"Hahm","year":"1999","journal-title":"Nat Genet"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0346\/3639842\/crc-24-0346.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/8\/1441\/3646290\/crc-24-0346.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/8\/1441\/3646290\/crc-24-0346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T02:38:15Z","timestamp":1756262295000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/8\/1441\/764368\/TGF-Inhibition-during-Radiotherapy-Enhances-Immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0346","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29992617","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992548","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992605","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992623","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992566","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992611","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992578","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992554","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992584","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992542","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992596","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992560","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992572","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992590","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992608","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992539","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992614","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992545","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992602","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992569","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992599","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992557","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992575","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992620","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992587","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992551","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992563","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992593","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29992581","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8002263","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}